Immunome, Inc. Share Price
IMNM$0.00
+0.00 (0.00%) Immunome, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Immunome, Inc. Share Price Chart
$0.00
Please wait...
About Immunome, Inc.
Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Immunome, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Immunome, Inc. Share Price
Can I buy Immunome, Inc. shares in India?
Yes. You can buy Immunome, Inc. in India by opening an international trading account.
What is the share price of Immunome, Inc.?
As on 01 Mar '26, the share price of Immunome, Inc. IMNM is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Immunome, Inc.?
The 5 year returns of Immunome, Inc. is as on 01 Mar '26.
What are the high & low stock price of Immunome, Inc. today?
Immunome, Inc. stock price hit a high of $0.00 and low of $0.00 as on 01 Mar '26.
What is the 52-week high and low of Immunome, Inc. stock?
The 52-week high of Immunome, Inc. stock is $0.00, while the 52-week low is $0.00 as on 01 Mar '26.